Norman N. KIM,William K. MCVICAR,Thomas G. MCCAULEY,Rudolf A. BAUMGARTNER
申请号：
US15158188
公开号：
US20160367586A1
申请日:
2016.05.18
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is directed to a combination or a kit comprising a prostaglandin analog and an adenosine receptor A1 agonist and to a method of reducing intraocular pressure (IOP) in a subject using such combination or kit. The invention is particularly directed to a combination of latanoprost marketed under the brand Xalatan™ and Compound A.
